Healthcare Technology Report September 4, 2024

Tempus AI, a pioneer in precision medicine and artificial intelligence, has extended its partnership with Remix Therapeutics, a clinical-stage biotechnology company that specializes in the development of small...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Partnerships, Pharma / Biotech, Precision Medicine, Technology, Trends
Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
Allowing Medicare to Negotiate Drug Prices Remains Broadly Popular Among Voters, Though Most Are Unaware of the Law and Its Projected Savings
Pharma Pulse 9/13/24: AI Adoption for Clinical Trial Design, Comparing Biologics and Biosimilars & more
3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders

Share This Article